Search

Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine

Specifically, the COVID-19 infection relies on the binding of the Spike protein to an ACEII receptor, and with the described approach, the vaccine uses these engineered minigenes to express viral proteins … As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.

Hydrocortisone phosphate

Deramciclane

Deramciclane differs from other anti anxiety medications in that it is not a benzodiazepine and so has a different structure and target.

SGS518

SGS518, a novel antagonist for the 5HT6 subtype of the serotonin receptor, is being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS).

Phentolamine

Phentolamine is a reversible, non-selective alpha-adrenergic blocker that induces vasodilation. While initially introduced to the market for the treatment of hypertension, this clinical use was halted due to cardiovascular and gastrointe...

Nitrofurantoin

[A179830] Nitrofurantoin was granted FDA approval on 6 February 1953.[L6895] … [A179824] This drug is more resistant to the development of bacterial resistance because it acts on many targets at once.

PTI-801

It is a combination of oxycodone with ultralow-dose naltrexone, an opioid antagonist.

ADX-10061

ADX10061 is a potent, selective antagonist of the dopamine D1 receptor. It is developed by Addex Pharmaceuticals for the treatment of nicotine dependence.

Rosmarinic acid

R411

It is not immunosuppressive, but blocks the activation and recruitment of cells involved in respiratory inflammation.